FDA Extends Review of AstraZeneca, Bristol Diabetes Drug Onglyza

The Food and Drug Administration announced Thursday that it needs additional time to complete the...

» read full story

April 23rd, 2009 - 21:13

FDA Panel Backs Bristol, AstraZeneca Diabetes Drug Onglyza

A federal panel of medical experts said Wednesday Bristol-Myers Squibb Co. and AstraZeneca...

» read full story

April 02nd, 2009 - 15:27

The Efficacy Of Gastric Bypass Surgery In Diabetics Questioned

Contrary to other studies, a new study found that people with diabetes did not lose as much weight...

» read full story

September 16th, 2008 - 14:00

Study: Byetta Is Better Than Januvia At Lowering Glucose Levels

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that a randomized, double-blind,...

» read full story

September 09th, 2008 - 20:43

Byetta Does Better Than Januvia In Trial

A twice-daily version of the popular Byetta diabetes treatment showed more efficiency for...

» read full story

September 09th, 2008 - 18:58

Bristol‘s Diabetes Drug Proves Efficient in Controlling Sugar

Experimental drug, saxagliptin from Bristol-Myers Squibb Co. and AstraZeneca proved efficient in...

» read full story

June 07th, 2008 - 21:13

Byetta Outruns Rival Januvia in Diabetes Trial

Eli Lilly and Co and Amylin Pharmaceuticals Inc’s diabetes drug Byetta proved better at reducing...

» read full story

September 10th, 2008 - 15:20